Sorry, Sanofi: More Bad News - Motley Fool

Sorry, Sanofi: More Bad News
Motley Fool -2 hours ago
Acomplia is approved in the European Union as a weight-loss treatment. But as The Wall Street Journal and other news sources reported, this week a British …

More: continued here